Bonti

Bonti

Bonti

Bonti is a rapidly emerging biotech company. Our lead product candidate is EB001, is used for both Therapeutic & Aesthetic needs.
Type
B2c
Founded
2015
Raised
$27.2M
Follow us
Alexa global traffic share
23 Jan 2018
$15,500,000
Venture capital (Series C)

Former Botox Bosses Raise $15.5 Million for Biotech Startup Bonti

VentureWire
+1